Ionis Pharmaceuticals, Inc.IONSNASDAQ
Loading
SG&A Expense Growth AcceleratingAccelerating
Percentile Rank77
3Y CAGR-4.4%
5Y CAGR-19.7%
Year-over-Year Change
Year-over-year SG&A expense growth
3Y CAGR
-4.4%/yr
Quarterly compound
5Y CAGR
-19.7%/yr
Recent acceleration
Percentile
P77
Within normal range
vs 5Y Ago
0.3x
Contraction
Streak
1 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q4 2025 | 34.30% |
| Q4 2025 | 6.84% |
| Q2 2025 | 18.74% |
| Q1 2025 | -13.39% |
| Q4 2024 | 43.02% |
| Q3 2024 | -5.38% |
| Q2 2024 | 23.66% |
| Q1 2024 | -25.85% |
| Q4 2023 | 1.43% |
| Q3 2023 | 51.71% |
| Q2 2023 | 1.38% |
| Q1 2023 | -4.98% |
| Q4 2022 | 39.24% |
| Q3 2022 | 1.78% |
| Q2 2022 | -0.96% |
| Q1 2022 | -11.59% |
| Q4 2021 | 28.24% |
| Q3 2021 | -33.26% |
| Q2 2021 | -21.02% |
| Q1 2021 | -58.88% |
| Q4 2020 | 102.99% |
| Q3 2020 | -5.02% |
| Q2 2020 | -3.98% |
| Q1 2020 | -9.94% |
| Q4 2019 | 38.71% |
| Q3 2019 | -20.07% |
| Q2 2019 | 10.10% |
| Q1 2019 | 3.27% |
| Q4 2018 | -3.86% |
| Q3 2018 | 3.80% |
| Q2 2018 | 51.65% |
| Q1 2018 | -4.49% |
| Q4 2017 | 70.62% |
| Q3 2017 | 20.03% |
| Q2 2017 | 63.17% |
| Q1 2017 | -24.19% |
| Q4 2016 | 77.09% |
| Q3 2016 | 3.71% |
| Q2 2016 | -6.99% |
| Q1 2016 | -19.87% |